Strikingly, the majority of CD56dim NK cells in IM patients was NKG2A+KIR− (Figure 2C), while in PTLD patients, the majority was NKG2A−KIR+ (Figure 2D). The gene discussed is KLRC1; the disease is post-transplant lymphoproliferative disease.